<![CDATA[Uptake: The EANM Podcast]]>Welcome to Uptake: the podcast of the European Association of Nuclear Medicine (EANM). Exploring the innovations, ideas, and people shaping the future of nuclear medicine — from the latest research and clinical developments to emerging technologies and bold new thinking in the field.

Hosted by Dr. Mariana Andrade, Uptake is designed for nuclear medicine professionals across all career stages and specializations, as well as students and anyone curious about the field.

]]>https://eanm.org/Riverside.fm (https://riverside.com)Fri, 11 Sep 2026 12:21:43 GMTTue, 03 Mar 2026 11:02:24 GMT60The European Association of Nuclear Medicine<p>Welcome to <i>Uptake</i>: the podcast of the European Association of Nuclear Medicine (<a rel="noopener noreferrer nofollow" href="https://eanm.org/" target="_blank">EANM</a>). Exploring the innovations, ideas, and people shaping the future of nuclear medicine — from the latest research and clinical developments to emerging technologies and bold new thinking in the field.</p><p>Hosted by Dr. Mariana Andrade, <i>Uptake</i> is designed for nuclear medicine professionals across all career stages and specializations, as well as students and anyone curious about the field.</p>episodicThe European Association of Nuclear Medicinee.muto@eanm.orgno<![CDATA[The Future of Nuclear Medicine: From Diagnosis to Disease Interception]]>In this first episode of Uptake: the EANM Podcast, we explore the central role of nuclear medicine in the emerging concept of disease interception — the shift from diagnosing diseases earlier to identifying them before they fully manifest, in order to alter their clinical trajectory at the earliest possible stage.

We're joined by two prominent guests: Prof. Paola Erba and Prof. Arturo Chiti. Together, they unpack what disease interception really means, why nuclear medicine is uniquely positioned to drive it, and where the field already puts the concept into practice.

The conversation ranges from the promise and risks associated with detecting biological signals before their clinical relevance is clear, to the role of theranostics in enabling interception, and where the research landscape points.

About our guests

Paola Erba is a nuclear medicine physician and a professor at the University of Milano-Bicocca and currently serves as President of the European Association of Nuclear Medicine (EANM).

Arturo Chiti is also a nuclear medicine physician and a professor at the Vita-Salute San Raffaele University in Milan. He is a former EANM President and currently Editor-in-Chief of The EANM Journal. 

Papers & studies mentioned

Cypess AM, et al., Identification and Importance of Brown Adipose Tissue in Adult Humans -- New England Journal of Medicine 2009;360(15):1509–1517.

The study is mentioned in the context of the conversation, and the above information is provided for further reading.

About our host

Dr. Mariana Andrade, a nuclear medicine physician at the Grand Hôpital de Charleroi, in Belgium, and former board member of the Belgian Society of Nuclear Medicine, is the voice of Uptake: the EANM Podcast.

Produced by Eliza Muto and Jeremy Braverman.

With technical support from the Central European University Library’s Media Hub.

Music: Domino by Ryan James Carr, licensed via Epidemic Sound.

]]>8c647bb6-7108-4dd5-8452-dd144accc5e8Tue, 01 Sep 2026 09:48:51 GMT<p>In this first episode of <i>Uptake: the EANM Podcast</i>, we explore the central role of nuclear medicine in the emerging concept of disease interception — the shift from diagnosing diseases earlier to identifying them before they fully manifest, in order to alter their clinical trajectory at the earliest possible stage.</p><p>We're joined by two prominent guests: Prof. Paola Erba and Prof. Arturo Chiti. Together, they unpack what disease interception really means, why nuclear medicine is uniquely positioned to drive it, and where the field already puts the concept into practice.</p><p>The conversation ranges from the promise and risks associated with detecting biological signals before their clinical relevance is clear, to the role of theranostics in enabling interception, and where the research landscape points.</p><p></p><p><b>About our guests</b></p><p>Paola Erba is a nuclear medicine physician and a professor at the University of Milano-Bicocca and currently serves as President of the <a rel="noopener noreferrer nofollow" href="https://eanm.org/" target="_blank">European Association of Nuclear Medicine</a> (EANM).</p><p>Arturo Chiti is also a nuclear medicine physician and a professor at the Vita-Salute San Raffaele University in Milan. He is a former EANM President and currently Editor-in-Chief of <a rel="noopener noreferrer nofollow" href="https://www.sciencedirect.com/journal/the-eanm-journal" target="_blank"><i>The EANM Journal</i></a>. </p><p></p><p><b>Papers &amp; studies mentioned</b></p><p>Cypess AM, et al., <i>Identification and Importance of Brown Adipose Tissue in Adult Humans</i> -- New England Journal of Medicine 2009;360(15):1509–1517.</p><p>The study is mentioned in the context of the conversation, and the above information is provided for further reading.</p><p></p><p><b>About our host</b></p><p>Dr. Mariana Andrade, a nuclear medicine physician at the Grand Hôpital de Charleroi, in Belgium, and former board member of the Belgian Society of Nuclear Medicine, is the voice of <i>Uptake: the EANM Podcast</i>.</p><p></p><p></p><p>Produced by Eliza Muto and Jeremy Braverman.</p><p>With technical support from the Central European University Library’s Media Hub.</p><p>Music: <i>Domino</i> by Ryan James Carr, licensed via Epidemic Sound.</p>no00:26:191The Future of Nuclear Medicine: From Diagnosis to Disease Interceptionfull